XML 23 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated other comprehensive income (loss)
Balance at the beginning at Dec. 31, 2020 $ (78,250)     $ 4,157 $ (82,642) $ 235
Balance (in Shares) at Dec. 31, 2020     10,376,000      
Balance at the beginning at Dec. 31, 2020   $ 111,432        
Balance (in Shares) at Dec. 31, 2020   104,822,000        
Issuance of Series C Preferred Stock for cash, net of offering costs   $ 34,793        
Issuance of Series C Preferred Stock for cash, net of offering costs (in Shares)   16,404,000        
Exercise of warrants 5     5    
Exercise of warrants (in Shares)     2,457,000      
Conversion of Convertible Preferred Stock to Common Stock 146,225 $ (146,225) $ 13 146,212    
Conversion of Convertible Preferred Stock to Common Stock, (in Shares)   (121,226,000) 121,226,000      
Reverse recapitalization, net of transaction costs 444,647   $ 6 444,641    
Reverse recapitalization, net of transaction costs (in Shares)     59,657,000      
Stock-based compensation 8,131     8,131    
Redemption of warrants, (in Shares)     148,000      
Common stock warrants issued to customers as consideration 121     121    
Common stock warrants related to marketing expense 810     810    
Net Income (Loss) (71,961)       (71,961)  
Other comprehensive loss (226)         (226)
Balance at the end at Dec. 31, 2021 449,502   $ 19 604,077 (154,603) 9
Balance (in Shares) at Dec. 31, 2021     193,864,000      
Exercise of warrants 3     3    
Exercise of warrants (in Shares)     1,874,000      
Reverse recapitalization, net of transaction costs (70)     (70)    
Stock-based compensation 13,716     13,716    
Tax withholdings related to net share settlement of equity awards (4,045)     (4,045)    
Tax withholdings related to net share settlement of equity awards, (in Shares)     (907,000)      
Issuance of common stock upon vesting of equity awards 1   $ 1      
Issuance of common stock upon vesting of equity awards ,(in Shares)     3,026,000      
Common stock warrants issued to customers as consideration 72     72    
Common stock warrants related to marketing expense 217     217    
Exercise of options 219     219    
Exercise of options (in Shares)     465,000      
Net settlement related to exercise of options (33)     (33)    
Net settlement related to exercise of options, (in Shares)     (5,000)      
ESPP Purchases 1,125     1,125    
ESPP Purchases (in shares)     208,000      
Net Income (Loss) (96,322)       (96,322)  
Other comprehensive loss (185)         (185)
Balance at the end at Dec. 31, 2022 364,200   $ 20 615,281 (250,925) (176)
Balance (in Shares) at Dec. 31, 2022     198,525,000      
Balance at the beginning at Dec. 31, 2022          
Balance (in Shares) at Dec. 31, 2022 0          
Stock-based compensation $ 13,271     13,271    
Tax withholdings related to net share settlement of equity awards (1,925)     (1,925)    
Tax withholdings related to net share settlement of equity awards, (in Shares)     (658,000)      
Issuance of common stock upon vesting of equity awards ,(in Shares)     2,259,000      
Common stock warrants issued to customers as consideration (193)     (193)    
Exercise of options 913     913    
Exercise of options (in Shares)     3,035,000      
Net settlement related to exercise of options, (in Shares)     (148,000)      
ESPP Purchases 809     809    
ESPP Purchases (in shares)     314,000      
Net Income (Loss) (34,587)       (34,587)  
Other comprehensive loss (40)         (40)
Balance at the end at Dec. 31, 2023 $ 342,448   $ 20 $ 628,156 $ (285,512) $ (216)
Balance (in Shares) at Dec. 31, 2023     203,327,000